Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes

The criteria for metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) remain controversial. This research aimed to identify a potential biomarker to differentiate the subtypes of obesity.

Source: Lipids in Health and Disease - October 4, 2023 Category: Lipidology Authors: Baowen Yu, Moran Hu, Wanzi Jiang, Yizhe Ma, Jingya Ye, Qinyi Wu, Wen Guo, Yan Sun, Min Zhou, Yiwen Xu, Zhoulu Wu, Yiwen Wang, Sin Man Lam, Guanghou Shui, Jingyu Gu, John Zhong Li & hellip; Tags: Research Source Type: research